BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22625191)

  • 21. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system.
    Binder RK; Schäfer U; Kuck KH; Wood DA; Moss R; Leipsic J; Toggweiler S; Freeman M; Ostry AJ; Frerker C; Willson AB; Webb JG
    JACC Cardiovasc Interv; 2013 Mar; 6(3):301-7. PubMed ID: 23517843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography.
    Clavel MA; Rodés-Cabau J; Dumont É; Bagur R; Bergeron S; De Larochellière R; Doyle D; Larose E; Dumesnil JG; Pibarot P
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1053-62. PubMed ID: 21999863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
    Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography.
    Leetmaa T; Hansson NC; Leipsic J; Jensen K; Poulsen SH; Andersen HR; Jensen JM; Webb J; Blanke P; Tang M; Nørgaard BL
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25873726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
    Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of failing biological prosthesis because of "Stent creep" with valve-in-valve transcatheter aortic valve implantation.
    Attia R; Papalexopoulou N; Hancock J; Young C; Thomas M; Bapat V
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):E119-25. PubMed ID: 24550020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of patients after transcatheter aortic valve embolization.
    Tay EL; Gurvitch R; Wijeysinghe N; Nietlispach F; Leipsic J; Wood DA; Yong G; Cheung A; Ye J; Lichtenstein SV; Carere R; Thompson C; Webb JG
    JACC Cardiovasc Interv; 2011 Feb; 4(2):228-34. PubMed ID: 21349463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement.
    Masri A; Schoenhagen P; Svensson L; Kapadia SR; Griffin BP; Tuzcu EM; Desai MY
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1847-54. PubMed ID: 23870156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation.
    Watanabe Y; Chevalier B; Hayashida K; Leong T; Bouvier E; Arai T; Farge A; Hovasse T; Garot P; Cormier B; Morice MC; Lefèvre T
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):323-30. PubMed ID: 25594190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height.
    De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H
    JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
    Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve.
    Webb J; Gerosa G; Lefèvre T; Leipsic J; Spence M; Thomas M; Thielmann M; Treede H; Wendler O; Walther T
    J Am Coll Cardiol; 2014 Dec; 64(21):2235-43. PubMed ID: 25456759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.
    Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S
    Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Balloon valvuloplasty treatment of an infolded CoreValve.
    Kaple RK; Salemi A; Wong SC
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):499-501. PubMed ID: 26508359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal prosthesis sizing in transcatheter aortic valve implantation by exclusive use of three-dimensional transoesophageal echocardiography.
    Kretzschmar D; Lauten A; Goebel B; Doenst T; Poerner TC; Ferrari M; Figulla HR; Hamadanchi A
    Clin Physiol Funct Imaging; 2016 Mar; 36(2):99-105. PubMed ID: 25316588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.